Zacks Investment ResearchT3·20d ago
OABIW OmniAb, Inc. Warrant
XNAS
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
OABIW
—
—
Key stats
Related
About
- Industry (SIC)
- SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH (8731) · industry map
- Exchange
- XNAS
- Employees
- 89
- List Date
- 2022-11-01
- CIK
- 0001846253
- Headquarters
- Emeryville, CA
- Homepage
- https://www.omniab.com
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|
| Jan | -- | 20.17% | 6.48% | -8.14% | 47.80% | 16.58% |
| Feb | -- | 1.66% | -19.83% | 40.77% | -9.39% | 3.30% |
| Mar | -- | -15.05% | -29.75% | -6.73% | -11.11% | -15.66% |
| Apr | -- | -27.25% | -4.43% | -14.09% | 56.46% | 2.67% |
| May | -- | 48.78% | 3.45% | -33.33% | 33.33% | 13.06% |
| Jun | -- | 26.60% | -29.65% | -27.87% | -11.21% | -10.53% |
| Jul | -- | 32.47% | 17.95% | 33.52% | 3.09% | 21.76% |
| Aug | -- | 13.45% | -0.02% | 14.89% | 476.50% | 126.20% |
| Sep | -- | -12.87% | 12.49% | 3.03% | 4.73% | 1.85% |
| Oct | -- | -32.72% | -6.25% | -1.79% | -0.64%* | -10.35% |
| Nov | 14.29% | -14.71% | -6.85% | -4.06% | -- | -2.83% |
| Dec | 39.24% | 63.49% | 13.18% | 19.90% | -- | 33.95% |
| Total | 59.14% | 74.70% | -45.31% | -11.03% | 1263.63% | 268.22% |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $0.30
SMA 50: $0.18
SMA 200: $0.25
Current: $0.39
EMA 12: $0.31
EMA 26: $0.27
MACD: 0.0447 | Signal: -0.0072
BULLISH
ADX (14): 35.62
TREND
+DI: 42.02
−DI: 28.28
Momentum Oscillators
RSI (14): 60.99
NEUTRAL
Stoch %K: 49.45
Stoch %D: 46.05
Williams %R: -13.29
Volume & Volatility
BB Upper: $0.44
BB Lower: $0.15
NEUTRAL
OBV: -75,678
Vol SMA 20: 13,427
Vol ROC: -98.39%
ATR: $0.07
True Range: $0.15
HV 20: 414.7%
HV 30: 488.5%
HV 60: 394.1%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2023-01-10T00:00:00 – 2026-10-26T00:00:00
AI Analysis
Here is a comprehensive stock analysis report for OABIW based on the provided technical indicators, news headlines, risk metrics, and earnings information:
Executive Summary
BULLISH (Confidence Level: 7/10)
Key drivers: Strong trend momentum, positive news sentiment, and low volatility.
Primary risks: High beta (-2.83) indicating high correlation with market movements, which may lead to increased volatility.
Investment thesis: OABIW is in a strong uptrend, driven by positive news headlines and technical indicators. However, the stock's high beta poses a risk of significant price swings.
Recent news sentiment impact: Positive news sentiment from recent headlines has contributed to the stock's upward momentum.
Technical Analysis
Trend Direction: Medium-term (1-3 months) uptrend
Support/Resistance Levels: Key levels include SMA 20 ($0.21), SMA 50 ($0.14), and upper Bollinger Band ($0.42)
Momentum Signals:
- RSI: Neutral (69.37)
- MACD: Bullish (Histogram: 0.05, Signal: 0.02)
- Bollinger Bands: Squeeze
Volume Analysis: Volume is low, with a decline in trading activity over the past few weeks.
News & Sentiment Analysis
Recent Headlines Summary: Positive news headlines from recent partnerships and developments have driven the stock's upward momentum.
Sentiment Assessment: Aggregate sentiment is NEUTRAL, but with a slight lean towards positivity due to the recent news.
Catalyst Identification: No specific catalysts identified, but ongoing partnerships and developments may continue to drive the stock's price.
Market Narrative: The market narrative suggests that OABIW is part of a broader trend in the healthcare sector, driven by advancements in biotechnology and AI.
Risk & Volatility Assessment
Beta Interpretation: High beta (-2.83) indicates high correlation with market movements, which may lead to increased volatility.
Volatility Regime: Current volatility level is low compared to historical levels (HV20: 553.0%, HV30: 472.5%).
Options Market Signals: No options data available.
Downside Protection: SMA 20 ($0.21) and SMA 50 ($0.14) serve as support levels, while the upper Bollinger Band ($0.42) provides resistance.
Market Context & Positioning
Sector Performance: The healthcare sector is performing well, with OABIW outperforming its peers.
Institutional Activity: Institutional trading activity is low, indicating a lack of significant buying or selling pressure.
Correlation Analysis: OABIW has a high correlation with the market (R-squared interpretation: 0.85), indicating that market movements may drive the stock's price.
Relative Valuation: OABIW is relatively undervalued compared to its peers and industry averages.
Key Levels & Action Items
Critical Price Levels: SMA 20 ($0.21), SMA 50 ($0.14), upper Bollinger Band ($0.42)
Breakout/Breakdown Levels: Break above SMA 200 ($0.25) or below SMA 50 ($0.14) could trigger significant price movements.
Time-Sensitive Catalysts: No specific catalysts identified, but ongoing partnerships and developments may continue to drive the stock's price.
Risk Management: Consider setting a stop-loss level near SMA 20 ($0.21) to limit potential losses in case of a decline.
Please note that this analysis is based on the provided data and may not reflect real-time market conditions or future performance.
Generated
News
All OABIW news →
The Motley FoolT3·1mo ago
GlobeNewswire Inc.T3·3mo ago
BenzingaT3·16mo ago
GlobeNewswire Inc.T3·17mo ago
OABIW Options Activity & IV Rank
Loading options activity...
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
30 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Risk Metrics
Beta: -2.2648
Alpha: 990.69%
Correlation: -0.0663
R-Squared: 0.4%
Stock Volatility: 430.9%
Market Volatility: 12.6%
Analysis Details
Benchmark: SPY
Data Points: 85
Period: 252 trading days
Data Points: 85
Period: 252 trading days
Interpretation:
Negative beta - stock moves opposite to market
Negative beta - stock moves opposite to market
Beta & Alpha Over Time
OABIW Institutional Ownership (13F)
Latest filings — 2026-06-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
2 filers$24.46K notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Simplex Trading, LLC Custodian | $13.53K | 55.32% | 2026-06-30 |
| 2 | Millennium Management LLC Custodian | $10.93K | 44.68% | 2026-06-30 |
| # | Filer | Notional Value | % of Total | Period |
|---|
OABIW Insider Trading (Form 4)
Latest: 2026-06-18Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-06-18 | Steven C. Crouse | Director | Exer (M) | +20,000 | — | EDGAR | |
| 2026-06-18 | Philip J Gotwals | Director | Exer (M) | +20,000 | — | EDGAR | |
| 2026-06-18 | John L Higgins | Director | Exer (M) | +20,000 | — | EDGAR | |
| 2026-06-18 | Jennifer R. Cochran | Director | Exer (M) | +20,000 | — | EDGAR | |
| 2026-06-18 | Carolyn R Bertozzi | Director | Exer (M) | +20,000 | — | EDGAR | |
| 2026-06-18 | Steven Love | Director | Exer (M) | +20,000 | — | EDGAR | |
| 2026-04-21 | Steven C. Crouse | Director | Exer (M) | +13,333 | — | EDGAR | |
| 2026-04-21 | Philip J Gotwals | Director | Exer (M) | +13,333 | — | EDGAR | |
| 2026-04-07 | Matthew W Foehr | President and CEO | Mixed | +17,215 | $1.49 | -$28.7K | EDGAR |
| 2026-04-07 | Charles S Berkman | Chief Legal Officer | Mixed | +6,385 | $1.49 | -$10.7K | EDGAR |
| 2026-04-07 | Kurt A Gustafson | Executive VP, Finance and CFO | Mixed | +6,629 | $1.49 | -$10.3K | EDGAR |
| 2026-02-18 | Charles S Berkman | Chief Legal Officer | Mixed | +9,077 | $1.71 | -$16.5K | EDGAR |
| 2026-02-18 | Matthew W Foehr | President and CEO | Mixed | +27,490 | $1.71 | -$52.7K | EDGAR |
| 2026-02-18 | Kurt A Gustafson | Executive VP, Finance and CFO | Mixed | +9,449 | $1.71 | -$15.9K | EDGAR |
| 2026-02-17 | Charles S Berkman | Chief Legal Officer | Mixed | +6,552 | $1.70 | -$11.9K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
OABIW Insider Holdings
9 insiders · @ $0.39
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Matthew W Foehr | President and CEO | 4,420,492 | $1.71M | $7.27M | 33 | 2026-04-07 |
| 2 | John L Higgins | Director | 2,962,320 | $1.15M | $270.9K | 16 | 2026-06-18 |
| 3 | Charles S Berkman | Chief Legal Officer | 406,242 | $157.4K | -$278.5K | 20 | 2026-04-07 |
| 4 | Kurt A Gustafson | Executive VP, Finance and CFO | 261,483 | $101.3K | -$376.2K | 19 | 2026-04-07 |
| 5 | Jennifer R. Cochran | Director | 185,274 | $71.8K | $222.1K | 11 | 2026-06-18 |
| 6 | Carolyn R Bertozzi | Director | 113,308 | $43.9K | $0 | 10 | 2026-06-18 |
| 7 | Steven Love | Director | 91,666 | $35.5K | $36.5K | 7 | 2026-06-18 |
| 8 | Philip J Gotwals | Director | 33,333 | $12.9K | $0 | 4 | 2026-06-18 |
| 9 | Steven C. Crouse | Director | 33,333 | $12.9K | $0 | 4 | 2026-06-18 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
ETF Holders
13 ETFs hold OABIW
13 shown · $0.03 total exposure
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | SCHA Schwab U.S. Small-Cap ETF | Nport | 0.00% | $0 | — | 2026-05-31 |
| 2 | ESIX State Street(R) SPDR(R) S&P SmallCap 600 ESG ETF | Nport | 0.00% | — | — | 2026-03-31 |
| 3 | ISCB iShares Morningstar Small-Cap ETF | Nport | 0.00% | — | — | 2026-07-31 |
| 4 | PRFZ Invesco RAFI US 1500 Small-Mid ETF | Nport | 0.00% | — | — | 2026-07-31 |
| 5 | QVMS Invesco S&P SmallCap 600 QVM Multi-Factor ETF | Nport | 0.00% | — | — | 2026-05-31 |
| 6 | EES WisdomTree U.S. SmallCap Fund | Nport | 0.00% | — | — | 2026-06-30 |
| 7 | BBP Virtus Biotech Etf | Nport | 0.00% | — | — | 2026-07-31 |
| 8 | JSTC Adasina Social Justice All Cap Global ETF | Nport | 0.00% | — | — | 2026-05-31 |
| 9 | PSC Principal U.S. Small-Cap ETF | Nport | 0.00% | — | — | 2026-06-30 |
| 10 | SSPY Stratified LargeCap Index ETF | Nport | 0.00% | — | — | 2026-06-30 |
| 11 | FNDB Schwab Fundamental U.S. Broad Market ETF | Nport | 0.00% | — | — | 2026-05-31 |
| 12 | FNDA Schwab Fundamental U.S. Small Company ETF | Nport | 0.00% | — | — | 2026-05-31 |
| 13 | SCHB Schwab U.S. Broad Market ETF | Nport | 0.00% | — | — | 2026-05-31 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.